Cargando…

Emerging Technologies for Percutaneous Mitral Valve Repair

Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangieri, Antonio, Laricchia, Alessandra, Giannini, Francesco, Gallo, Francesco, Kargoli, Faraj, Ladanyi, Annamaria, Testa, Luca, Colombo, Antonio, Latib, Azeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851532/
https://www.ncbi.nlm.nih.gov/pubmed/31781576
http://dx.doi.org/10.3389/fcvm.2019.00161
_version_ 1783469637462130688
author Mangieri, Antonio
Laricchia, Alessandra
Giannini, Francesco
Gallo, Francesco
Kargoli, Faraj
Ladanyi, Annamaria
Testa, Luca
Colombo, Antonio
Latib, Azeem
author_facet Mangieri, Antonio
Laricchia, Alessandra
Giannini, Francesco
Gallo, Francesco
Kargoli, Faraj
Ladanyi, Annamaria
Testa, Luca
Colombo, Antonio
Latib, Azeem
author_sort Mangieri, Antonio
collection PubMed
description Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and echocardiographic outcomes. However, even if transcatheter mitral valve replacement (TMVR) will have a role in the future of percutaneous treatment of both functional and degenerative mitral regurgitation, percutaneous mitral valve repair will always play a vital role in the treatment of MR because of the favorable safety profile and the fact that it respects the native anatomy. In this review, we will discuss the new emerging technologies under development to treat mitral regurgitation focusing on different devices that aim to target different components of the mitral anatomy.
format Online
Article
Text
id pubmed-6851532
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68515322019-11-28 Emerging Technologies for Percutaneous Mitral Valve Repair Mangieri, Antonio Laricchia, Alessandra Giannini, Francesco Gallo, Francesco Kargoli, Faraj Ladanyi, Annamaria Testa, Luca Colombo, Antonio Latib, Azeem Front Cardiovasc Med Cardiovascular Medicine Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and echocardiographic outcomes. However, even if transcatheter mitral valve replacement (TMVR) will have a role in the future of percutaneous treatment of both functional and degenerative mitral regurgitation, percutaneous mitral valve repair will always play a vital role in the treatment of MR because of the favorable safety profile and the fact that it respects the native anatomy. In this review, we will discuss the new emerging technologies under development to treat mitral regurgitation focusing on different devices that aim to target different components of the mitral anatomy. Frontiers Media S.A. 2019-11-06 /pmc/articles/PMC6851532/ /pubmed/31781576 http://dx.doi.org/10.3389/fcvm.2019.00161 Text en Copyright © 2019 Mangieri, Laricchia, Giannini, Gallo, Kargoli, Ladanyi, Testa, Colombo and Latib. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Mangieri, Antonio
Laricchia, Alessandra
Giannini, Francesco
Gallo, Francesco
Kargoli, Faraj
Ladanyi, Annamaria
Testa, Luca
Colombo, Antonio
Latib, Azeem
Emerging Technologies for Percutaneous Mitral Valve Repair
title Emerging Technologies for Percutaneous Mitral Valve Repair
title_full Emerging Technologies for Percutaneous Mitral Valve Repair
title_fullStr Emerging Technologies for Percutaneous Mitral Valve Repair
title_full_unstemmed Emerging Technologies for Percutaneous Mitral Valve Repair
title_short Emerging Technologies for Percutaneous Mitral Valve Repair
title_sort emerging technologies for percutaneous mitral valve repair
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851532/
https://www.ncbi.nlm.nih.gov/pubmed/31781576
http://dx.doi.org/10.3389/fcvm.2019.00161
work_keys_str_mv AT mangieriantonio emergingtechnologiesforpercutaneousmitralvalverepair
AT laricchiaalessandra emergingtechnologiesforpercutaneousmitralvalverepair
AT gianninifrancesco emergingtechnologiesforpercutaneousmitralvalverepair
AT gallofrancesco emergingtechnologiesforpercutaneousmitralvalverepair
AT kargolifaraj emergingtechnologiesforpercutaneousmitralvalverepair
AT ladanyiannamaria emergingtechnologiesforpercutaneousmitralvalverepair
AT testaluca emergingtechnologiesforpercutaneousmitralvalverepair
AT colomboantonio emergingtechnologiesforpercutaneousmitralvalverepair
AT latibazeem emergingtechnologiesforpercutaneousmitralvalverepair